Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and pharmacokinetics (PK) of XOMA 052 in
subjects with stable Type 2 Diabetes Mellitus (T2D).
The study is a dose-escalation study designed to evaluate route of administration
(intravenous or subcutaneous), doses, and dosing regimens for future studies.